loadpatents
name:-0.03071403503418
name:-0.026279211044312
name:-0.0062720775604248
Ruediger; Edward H. Patent Filings

Ruediger; Edward H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ruediger; Edward H..The latest application filed is for "imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggre".

Company Profile
6.47.51
  • Ruediger; Edward H. - Montreal CA
  • Ruediger; Edward H. - Greenfield Park CA
  • Ruediger; Edward H. - Quebec CA
  • Ruediger, Edward H - Greenfield Park CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biarylmethyl heterocycles
Grant 11,407,733 - Priestley , et al. August 9, 2
2022-08-09
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,822,343 - Banville , et al. November 3, 2
2020-11-03
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggre
App 20200123160 - Banville; Jacques ;   et al.
2020-04-23
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,428,077 - Banville , et al. October 1, 2
2019-10-01
Biarylmethyl Heterocycles
App 20190202808 - PRIESTLEY; Eldon Scott ;   et al.
2019-07-04
Benzothiazole and benzothiophene compounds
Grant 10,238,638 - Ruediger , et al.
2019-03-26
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggregation
App 20180305376 - Banville; Jacques ;   et al.
2018-10-25
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,047,103 - Banville , et al. August 14, 2
2018-08-14
Benzothiazole And Benzothiophene Compounds
App 20180036287 - RUEDIGER; Edward H. ;   et al.
2018-02-08
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,862,730 - Lawrence , et al. January 9, 2
2018-01-09
Hepatitis C virus inhibitors
Grant 9,758,487 - Bachand , et al. September 12, 2
2017-09-12
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggregation
App 20170247395 - Banville; Jaques ;   et al.
2017-08-31
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,688,695 - Banville , et al. June 27, 2
2017-06-27
Tricyclic alkene derivatives as HIV attachment inhibitors
Grant 9,655,888 - Wang , et al. May 23, 2
2017-05-23
Piperidine amide derivatives as HIV attachment inhibitors
Grant 9,505,752 - Wang , et al. November 29, 2
2016-11-29
Hepatitis C Virus Inhibitors
App 20160311778 - Bachand; Carol ;   et al.
2016-10-27
Hepatitis C virus inhibitors
Grant 9,227,961 - Bachand , et al. January 5, 2
2016-01-05
Piperidine Amide Derivatives As Hiv Attachment Inhibitors
App 20150210684 - Wang; Tao ;   et al.
2015-07-30
Tricyclic Alkene Derivatives As Hiv Attachment Inhibitors
App 20150190387 - Wang; Tao ;   et al.
2015-07-09
Imidazothiadiazole Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150133446 - Lawrence; R. Michael ;   et al.
2015-05-14
Hepatitis C virus inhibitors
Grant 9,018,390 - Bachand , et al. April 28, 2
2015-04-28
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150094297 - Banville; Jacques ;   et al.
2015-04-02
Hepatitis C Virus Inhibitors
App 20150011754 - Bachand; Carol ;   et al.
2015-01-08
Hepatitis C virus inhibitors
Grant 8,846,023 - Bachand , et al. September 30, 2
2014-09-30
Hepatitis C virus inhibitors
Grant 8,642,025 - Bachand , et al. February 4, 2
2014-02-04
Hepatitis C Virus Inhibitors
App 20140018389 - Lavoie; Rico ;   et al.
2014-01-16
Hepatitis C Virus Inhibitors
App 20140017195 - Bachand; Carol ;   et al.
2014-01-16
Hepatitis C virus inhibitors
Grant 8,574,563 - Bachand , et al. November 5, 2
2013-11-05
Hepatitis C Virus Inhibitors
App 20130280211 - Bachand; Carol ;   et al.
2013-10-24
Hepatitis C virus inhibitors
Grant 8,492,553 - Bachand , et al. July 23, 2
2013-07-23
Hepatitis C Virus Inhibitors
App 20130034520 - Bachand; Carol ;   et al.
2013-02-07
Hepatitis C Virus Inhibitors
App 20130012540 - Lavoie; Rico ;   et al.
2013-01-10
Hepatitis C Virus Inhibitors
App 20130004457 - Bachand; Carol ;   et al.
2013-01-03
Hepatitis C Virus Inhibitors
App 20120328570 - Bachand; Carol ;   et al.
2012-12-27
Hepatitis C virus inhibitors
Grant 8,303,944 - Bachand , et al. November 6, 2
2012-11-06
Hepatitis C virus inhibitors
Grant 8,288,562 - Bachand , et al. October 16, 2
2012-10-16
Hepatitis C virus inhibitors
Grant 8,211,928 - Lavoie , et al. July 3, 2
2012-07-03
Hepatitis C virus inhibitors
Grant 8,147,818 - Bachand , et al. April 3, 2
2012-04-03
Hepatitis C virus inhibitors
Grant 8,143,414 - Lavoie , et al. March 27, 2
2012-03-27
Hepatitis C virus inhibitors
Grant 8,093,243 - Bachand , et al. January 10, 2
2012-01-10
Hepatitis C Virus Inhibitors
App 20110281910 - Lavoie; Rico ;   et al.
2011-11-17
Hepatitis C Virus Inhibitors
App 20110130433 - Lavoie; Rico ;   et al.
2011-06-02
Hepatitis C Virus Inhibitors
App 20110098327 - Lavoie; Rico ;   et al.
2011-04-28
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
Grant 7,915,283 - Wang , et al. March 29, 2
2011-03-29
Hepatitis C Virus Inhibitors
App 20100233120 - Bachand; Carol ;   et al.
2010-09-16
Hepatitis C virus inhibitors
Grant 7,759,495 - Bachand , et al. July 20, 2
2010-07-20
Hepatitis C virus inhibitors
Grant 7,745,636 - Bachand , et al. June 29, 2
2010-06-29
Hepatitis C virus inhibitors
Grant 7,741,347 - Bachand , et al. June 22, 2
2010-06-22
Hepatitis C virus inhibitors
Grant 7,704,992 - Bachand , et al. April 27, 2
2010-04-27
Hepatitis C virus inhibitors
Grant 7,659,270 - Bachand , et al. February 9, 2
2010-02-09
Hepatitis C Virus Inhibitors
App 20090233925 - Bachand; Carol ;   et al.
2009-09-17
Hepatitis C Virus Inhibitors
App 20090202483 - Bachand; Carol ;   et al.
2009-08-13
Hepatitis C Virus Inhibitors
App 20090202478 - Bachand; Carol ;   et al.
2009-08-13
Hepatitis C Virus Inhibitors
App 20090068140 - Bachand; Carol ;   et al.
2009-03-12
4-Squarylpiperazine derivatives as antiviral agents
Grant 7,501,419 - Bachand , et al. March 10, 2
2009-03-10
Hepatitis C Virus Inhibitors
App 20080311075 - Bachand; Carol ;   et al.
2008-12-18
Hepatitis C Virus Inhibitors
App 20080299075 - Bachand; Carol ;   et al.
2008-12-04
Tetrahydrocarboline antiviral agents
Grant 7,449,476 - Ruediger , et al. November 11, 2
2008-11-11
Indole, Azaindole And Related Heterocyclic 4-alkenyl Piperidine Amides
App 20080188481 - Wang; Tao ;   et al.
2008-08-07
Piperazine amidines as antiviral agents
Grant 7,396,830 - Wang , et al. July 8, 2
2008-07-08
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
Grant 7,348,337 - Wang , et al. March 25, 2
2008-03-25
Hepatitis C Virus Inhibitors
App 20080050336 - Bachand; Carol ;   et al.
2008-02-28
Hepatitis C Virus Inhibitors
App 20080044379 - Bachand; Carol ;   et al.
2008-02-21
Hepatitis C Virus Inhibitors
App 20080044380 - Bachand; Carol ;   et al.
2008-02-21
4-Squarylpiperazine Derivatives as Antiviral Agents
App 20070249624 - Bachand; Carol ;   et al.
2007-10-25
Piperazine amidines as antiviral agents
App 20070078141 - Wang; Tao ;   et al.
2007-04-05
Topoisomerase inhibitors
Grant 7,138,377 - Ruediger , et al. November 21, 2
2006-11-21
Pyrrolotriazine compounds
Grant 7,102,003 - Gavai , et al. September 5, 2
2006-09-05
Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same
Grant 7,067,525 - Yu , et al. June 27, 2
2006-06-27
Di-substituted pyrrolotriazine compounds
Grant 7,064,203 - Gavai , et al. June 20, 2
2006-06-20
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20060025403 - Yu; Guixue ;   et al.
2006-02-02
Pyrrolotriazine compounds
App 20060014745 - Gavai; Ashvinikumar V. ;   et al.
2006-01-19
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
Grant 6,979,691 - Yu , et al. December 27, 2
2005-12-27
Tetrahydrocarboline antiviral agents
App 20050267130 - Ruediger, Edward H. ;   et al.
2005-12-01
Di-substituted pyrrolotrizine compounds
App 20050197339 - Gavai, Ashvinikumar V. ;   et al.
2005-09-08
Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
Grant 6,855,698 - Ruediger , et al. February 15, 2
2005-02-15
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20040229882 - Yu, Guixue ;   et al.
2004-11-18
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
App 20040186292 - Wang, Tao ;   et al.
2004-09-23
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
App 20040063744 - Wang, Tao ;   et al.
2004-04-01
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
Grant 6,713,487 - Yu , et al. March 30, 2
2004-03-30
Anhydro sugar derivatives of indolocarbazoles
Grant 6,686,385 - Saulnier , et al. February 3, 2
2004-02-03
Topoisomerase inhibitors
Grant 6,677,450 - Saulnier , et al. January 13, 2
2004-01-13
Anhydro Sugar Derivatives Of Indolocarbazoles
App 20030220387 - Saulnier, Mark G. ;   et al.
2003-11-27
Use of bioactive metabolites of gepirone for the treatment of psychological disorders
App 20030220346 - Kramer, Stephen J. ;   et al.
2003-11-27
Tumor proliferation inhibitors
Grant 6,653,290 - Ruediger , et al. November 25, 2
2003-11-25
Topoisomerase inhibitors
App 20030203860 - Ruediger, Edward H. ;   et al.
2003-10-30
Anhydro sugar derivatives of indolocarbazoles
Grant 6,610,727 - Saulnier , et al. August 26, 2
2003-08-26
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20030096827 - Yu, Guixue ;   et al.
2003-05-22
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20030092732 - Yu, Guixue ;   et al.
2003-05-15
Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
App 20030083271 - Ruediger, Edward H. ;   et al.
2003-05-01
Antianxiety composition
App 20030069251 - Yevich, Joseph P. ;   et al.
2003-04-10
Anhydro sugar derivatives of indolocarbazoles
App 20020111375 - Saulnier, Mark G. ;   et al.
2002-08-15
Topoisomerase inhibitors
App 20020107237 - Saulnier, Mark G. ;   et al.
2002-08-08
Tumor proliferation inhibitors
App 20020068705 - Ruediger, Edward H. ;   et al.
2002-06-06
Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
Grant 5,618,816 - Crenshaw , et al. April 8, 1
1997-04-08
Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]de cane-7,9-dione
Grant 4,956,368 - Cipollina , et al. September 11, 1
1990-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed